Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment

Digestive Diseases and Sciences

Volumn 43, Issue 12, 1998, Pages 2573-2576

  Dufour, Jean Francois ^a   Delellis, Ronald ^a   Kaplan, Marshall M ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Fibrosis; Hepatitis C; Interferon

Indexed keywords

ALPHA INTERFERON; VIRUS RNA;

ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; HEPATITIS C; HUMAN; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER HISTOLOGY; LIVER NECROSIS; PRIORITY JOURNAL; REMISSION; TREATMENT INDICATION;

ADULT; ALANINE TRANSAMINASE; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; LIVER; LIVER CIRRHOSIS; RNA, MESSENGER; TREATMENT OUTCOME;

EID: 0032410557     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026601904609     Document Type: Article

References (17)

1. Tong MJ, el-Farra NS, Reikes AR, Co RL: Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 332:1463-1466, 1995
2. Poynard T, Bedossa P, Chevallier M: A comparison of three Interferon alpha-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med 332:1457-1462, 1995
3. Knodell RG, Ishak KG, Black WC, Chen TS, Craig K, Kaplowitz N, Kiernan TW, Wollman J: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431-435, 1981
4. Powell LW, Kerr JFR: Reversal of cirrhosis in idiopathic hemochromatosis following long-term intensive venesection therapy. Australas Ann Med 2:54, 1970
5. Falkmer S, Samuelson G, Sjolin S: Penicillamine-induced normalization of clinical signs and normal liver morphology and histochcmistry in a case of Wilson's disease. Pediatrics 45:260-268, 1970
6. Kaplan MM, DeLellis RA, Wolfe HJ: Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment. Ann Intern Med 126:682-688, 1997
7. Dufour J-F, DeLellis RA, Kaplan MM: Reversibility of hepatic fibrosis in autoimmune hepatitis. Ann Intern Med 127:981-985, 1997
8. Crawford JM: The liver and the biliary tract. In Pathologic Basis of Disease. RS Cotran, V Kumar, SL Robbins (eds). Philadelphia, WB Saunders Company, 1994, pp 831-896
9. Hall P, De la M: Alcoholic liver disease. In Pathology of the Liver, 2nd ed. RNM McSween, P Anthony, PJ Scheuer, (eds). Edinburgh, Churchill Livingstone, 1987, p 291
10. Castilla A, Prieto J, Fausto N: Transforming growth factors β1 and α in chronic liver disease: Effects of interferon alpha therapy: N Engl J Med 324:933-940, 1991
11. Mallat A, Preaux A-M, Blazejewski S, Rosenbaum J, Dhumeaux D, Mavier P: Interferon alpha and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture. Hepatology 21:1003-1010, 1945
12. Berman B, Duncan MR: Short-term keloid treatment in vivo with human interferon alpha-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro. J Am Acad Dermatol 21:694-702, 1989
13. Camps J, Castilla A, Ruiz J, Civeira MP, Prieto J: Randomised trial of lymphoblastoid intergeron α in chronic hepatitis C. J Hepatol 17:390-396, 1993
14. Manabe N, Chevallier M, Chossegros P, Causse X, Guerret S, Trepo C, Grimaud J-A: Interferon α-2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: A quantitative histological evaluation. Hepalology 18:1344-1349, 1993
15. Hiramatsu N, Hayashi N, Kasahara A, Hagiwara H, Takehara T, Haruna Y, Naito M, Fusamoto H, Kamada T: Improvement of liver fibrosis in chronic hepatitis C patients treated with natural interferon alpha. J Hepatol 22:135-142, 1995
16. Ziol M, Tran Van Nhieu J, Roudot-Thoraval F, Métrcau J-M, Deugnier Y, Dhumeaux D, Zafrani E: A histopathological study of the effects of 6-month versus 12-month interferon α-2b therapy in chronic hepatitis C. J Hepatol 25:833-841, 1996
17. Abdi W, Millan JC, Mezey E: Sampling variability on percutaneous liver biopsy. Arch Intern Med 39:667-669, 1979